Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the United States. The company's lead product candidate is soquelitinib (CPI-818), a...
115 insider purchases on record · latest filing 2026-06-15.
Insiders have also filed 11 sale transactions at CRVS.